Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 10.06% is 54% below its 5-year average of 21.71%, near the low end of its 5-year range (1.75%–36.16%).
10.91% below its 12-month average of 11.29%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 10.14%.
OPERATING MARGIN
10.06%
OPERATING MARGIN AVG TTM
11.29%
OPERATING MARGIN AVG 3Y
13.26%
OPERATING MARGIN AVG 5Y
21.71%
OPERATING MARGIN AVG 10Y
20.43%
OPERATING MARGIN AVG 15Y
15.37%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-10.91%
CURRENT VS 3Y AVG
-24.11%
CURRENT VS 5Y AVG
-53.67%
CURRENT VS 10Y AVG
-50.75%
CURRENT VS 15Y AVG
-34.56%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Acadia Healthcare Company, Inc.
Market Cap
$2.69B
Operating Margin
10.06%
TTM Avg
11.29%
3Y Avg
13.26%
5Y Avg
21.71%
Market Cap
$2.72B
Operating Margin
11.12%
TTM Avg
10.91%
3Y Avg
6.08%
5Y Avg
-3.97%
Market Cap
$2.66B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
Market Cap
$2.74B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.55B
Operating Margin
-42.22%
TTM Avg
-21.11%
3Y Avg
-21.11%
5Y Avg
-21.11%
Market Cap
$2.82B
Operating Margin
12.21%
TTM Avg
13.21%
3Y Avg
-4.78%
5Y Avg
-42.05%
Market Cap
$2.84B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.48B
Operating Margin
-867.87%
TTM Avg
-840.98%
3Y Avg
-774.76%
5Y Avg
-1234.34%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acadia Healthcare Company, Inc. (ACHC) | $2.69B | 10.06% | 11.29% | 13.26% | 21.71% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.72B | 11.12% | 10.91% | 6.08% | -3.97% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.66B | -274.57% | -464.41% | -382.79% | -92575.80% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.74B | 0.00% | 0.00% | 0.00% | 0.00% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.55B | -42.22% | -21.11% | -21.11% | -21.11% |
| TransMedics Group, Inc. (TMDX)vs › | $2.82B | 12.21% | 13.21% | -4.78% | -42.05% |
| AtriCure, Inc. (ATRC)vs › | $2.83B | 2.44% | -4.62% | -7.21% | -5.02% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.84B | 0.00% | 0.00% | 0.00% | 0.00% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.48B | -867.87% | -840.98% | -774.76% | -1234.34% |
| Liquidia Corporation (LQDA)vs › | $2.47B | -32.45% | -449.54% | -390.50% | -1635.66% |
Gross Margin
17.6%
Operating Margin
10.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 10.14% |
| 2026-03-31 | 10.12% |
| 2025-12-31 | 5.80% |
| 2025-09-30 | 14.04% |
| 2025-06-30 | 16.37% |
| 2025-03-31 | 1.75% |
| 2024-12-31 | 13.36% |
| 2024-09-30 | 18.05% |
| 2024-06-30 | 17.93% |
| 2024-03-31 | 16.78% |
| 2023-12-31 | 16.83% |
| 2023-09-30 | 17.90% |
| 2023-06-30 | 35.97% |
| 2023-03-31 | 33.30% |
| 2022-12-31 | 34.31% |
| 2022-09-30 | 35.53% |
| 2022-06-30 | 36.16% |
| 2022-03-31 | 33.90% |
| 2021-12-31 | 34.49% |
| 2021-09-30 | 17.89% |
| 2021-06-30 | 35.38% |
| 2021-03-31 | 33.48% |
| 2020-12-31 | 32.98% |
| 2020-09-30 | 35.92% |
| 2020-06-30 | 31.55% |
| 2020-03-31 | 31.39% |
| 2019-12-31 | 12.77% |
| 2019-09-30 | 13.12% |
| 2019-06-30 | 14.39% |
| 2019-03-31 | 11.74% |
| 2018-12-31 | 12.33% |
| 2018-09-30 | 13.67% |
| 2018-06-30 | 15.40% |
| 2018-03-31 | 13.34% |
| 2017-12-31 | 15.36% |
| 2017-09-30 | 15.58% |
| 2017-06-30 | 16.70% |
| 2017-03-31 | 14.04% |
| 2016-12-31 | 15.39% |
| 2016-09-30 | 15.28% |
| 2016-06-30 | 17.00% |
| 2016-03-31 | 15.58% |
| 2015-12-31 | 17.63% |
| 2015-09-30 | 17.98% |
| 2015-06-30 | 18.85% |
| 2015-03-31 | 16.87% |
| 2014-12-31 | 17.76% |
| 2014-09-30 | 17.64% |
| 2014-06-30 | 12.46% |
| 2014-03-31 | 15.93% |
| 2013-12-31 | 17.29% |
| 2013-09-30 | 17.72% |
| 2013-06-30 | 17.52% |
| 2013-03-31 | 16.32% |
| 2012-12-31 | 20.31% |
| 2012-09-30 | 17.21% |
| 2012-06-30 | 9.97% |
| 2012-03-31 | 13.49% |
| 2011-12-31 | -24.38% |
| 2011-09-30 | 10.33% |
| 2011-06-30 | -29.80% |
| 2011-03-31 | -1.81% |
| 2010-12-31 | 15.50% |
| 2010-09-30 | 12.68% |
